Type 1 diabetes - The best data supporting angiotensin inhibition in patients with type 1 diabetes come from a trial of 409 adult participants who had urine protein excretion ≥500 mg / day and a serum creatinine ≤2.5 mg / dL (221 micromol / L) [45, 46].